Full history for every metric is available with a Kvantra account
Forian Inc. (FORA)
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1 | 17 | 16 | 20 | 20 | 30 | 30 |
| Operating profit | $m | -2 | -4 | |||||
| Net profit | $m | -5 | -27 | -26 | 11 | -4 | -3 | -5 |
| EPS reported | $ | -0.09 | -0.17 | |||||
| Operating cashflow per share | $ | 0.09 | 0.06 | |||||
| Capex per share | $ | 0.00 | 0.01 | |||||
| FCF per share | $ | 0.09 | 0.06 | |||||
| Free cash flow | $m | 3 | 2 | |||||
| Net debt | $m | -32 | -31 | |||||
| Book value equity | $m | 30 | 27 | |||||
| Book value per share | $ | 0.96 | 0.86 | |||||
| Number of shares | m | 31.11 | 31.15 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.21 | 2.52 | |||||
| P/S LTM | x | 2.18 | 2.26 | |||||
| P/FCF LTM | x | 22.85 | 35.86 | |||||
| EV/EBITDA LTM | x | -23.35 | -8.12 | |||||
| EV/Sales LTM | x | 1.75 | 1.23 | |||||
| Earnings Yield LTM | % | -4.36% | -7.56% | |||||
| FCF Yield | % | 4.38% | 2.79% | |||||
| Quality | ||||||||
| ROE | % | -9.65% | -17.22% | |||||
| ROIC | % | -8.29% | -14.93% | |||||
| Operating margin | % | -8.16% | -13.36% | |||||
| Gross margin | % | 52.52% | 46.85% | |||||
| FCF/Sales | % | 9.54% | 6.29% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +50.13% | +34.57% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | +920.58% | -35.68% | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 237.82 | 309.68 | |||||
| Net Debt/EBITDA | x | 5.67 | 6.82 | |||||
| EBIT/Net interest | x | -17.34 | -44.79 | |||||
| Net debt/market cap | % | -47.84% | -45.66% | |||||
| Net debt/Equity | x | -1.06 | -1.15 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Forian Inc. (FORA)
Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free